CDCP1 and familial pancreatic carcinoma: The present study demonstrates the utility of a89Zr-labelled CDCP1-directed agent (10D7) for CRC and also extends the ovarian and pancreatic cancer studies by demonstrating the selectivity of 89Zr-10D7 for CDCP1 expressing tumors using unlabelled 10D7.